secwatch.observer — SEC 8-K summary
======================================

Issuer:     ULTRALIFE CORP (ULBI)
CIK:        0000875657
Form:       8-K
Filed at:   2022-07-28T23:59:59+00:00
Accession:  0001437749-22-017937
Event type: earnings
Sentiment:  negative
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultralife Q2 revenue up 20% to $32.1M; net income falls to $0.5M from $0.8M
---------------------------------------------------------------------------

- Revenue $32.1M (+20% YoY); net income $0.5M ($0.03 diluted EPS) vs $0.8M ($0.05) prior year.
- Operating income $0.8M vs $1.1M; gross margin 23.8% vs 27.1% on supply chain disruption and inflation.
- Battery & Energy sales +31.8% to $30.1M, boosted by Excell acquisition ($6.6M) and commercial growth; Communications Systems -49% to $2.0M on supply delays.
- Adjusted EBITDA flat at $2.2M (6.8% of sales vs 8.2%).
- CEO cites supply chain constraints delaying govt/defense shipments; expects continued challenges in H2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875657/000143774922017937/0001437749-22-017937-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875657/000143774922017937/ulbi20220727_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-017937

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer